Skip to main navigation

Histogenics

  • About Us
    • History
    • Management
    • Board of Directors
    • Scientific Advisory Board
  • Products & Platforms
    • NeoCart
    • Platform
    • About Restorative Cell Therapies
    • About Cartilage Repair
  • Partnering
    • Brigham and Women’s Hospital
    • Cornell University
    • MEDINET
  • Investors
    • Stock Information
    • SEC Filings
    • Calendar of Events
    • Presentations & Publications
    • Analytists
    • Corporate Governance
    • Investors FAQs
  • News
    • Press Releases
  • Contact
    • Subscribe
  • Careers
Home/ Investors/ SC 13D/A

Investors

Investor Relations

  • Investor Overview
  • Stock Information
  • SEC Filings
  • Calendar of Events
  • Presentations & Publications
  • Analysts
  • Corporate Governance
  • Investor FAQs

SEC Filing Details

Document Details

Form
SC 13D/A
Filing Date
Jan 15, 2019
Document Date
Jan 15, 2019
Form Description
An amendment to a SC 13D filing
Filing Group
3,4,5
Company
Histogenics Corp
Issuer
HISTOGENICS CORP

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Shareholder Tools

  • Print Page
  • RSS Feeds
  • E-mail Alerts
  • IR Contacts

830 Winter Street, 3rd Floor

Waltham, MA 02451

tel 781.547.7900

fax 781.547.4452

Email: InvestorRelations@histogenics.com

Accounts Payable Email: accountspayable@histogenics.com

About Us

  • History
  • Management
  • Board of Directors
  • Scientific Advisory Board

Products & Platform

  • Products & Platforms
  • NeoCart
  • Platform
  • About Restorative Cell Therapies
  • About Cartilage Repair

Investors

  • Investor Overview
  • Stock Information
  • SEC Filings
  • Calendar of Events
  • Presentations & Publications
  • Analysts
  • Corporate Governance
  • Investor FAQs

News

  • Press Releases

Contact

  • Contact
  • Subscribe
  • Careers

Copyright © 2018 · Histogenics
Terms & Conditions | Forward Looking Statements